Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jun;16(2):117-122.
doi: 10.17245/jdapm.2016.16.2.117. Epub 2016 Jun 30.

Comparative study of analgesia with bupivacaine 0.25% versus 0.5% for third molar removal under general anesthesia

Affiliations

Comparative study of analgesia with bupivacaine 0.25% versus 0.5% for third molar removal under general anesthesia

Parmanand Dhanrajani et al. J Dent Anesth Pain Med. 2016 Jun.

Abstract

Background: The aim of this study was to compare the effectiveness and duration of action of two concentrations of bupivacaine with adrenaline for postoperative pain in patients undergoing surgical removal of four third molars under general anesthesia.

Methods: Sixty patients undergoing surgical removal of four wisdom teeth received bupivacaine 0.5% (n = 30) or 0.25% (n = 30). The severity of pain in the immediate recovery period and at 2 and 24 h after surgery was recorded using the visual analogue scale. Differences were assessed by box and whisper plot and the Student's t-test.

Results: The analgesic effects of the 0.25% and 0.5% doses were significantly different (P = 0.022) at 30 min after surgery but not after 2 and 24 h. The difference of mean of 0.25% and 0.5% was much higher after 0.5 h but less after 2 and 24 h.

Conclusions: Bupivacaine 0.5% was statistically better for pain control during the immediate postoperative period, but there was no significant difference in pain control between the two dose strengths at 2 and 24 h after surgery.

Keywords: Bupivacaine; Extraction; Local anesthesia; Third molars.

PubMed Disclaimer

Conflict of interest statement

Declaration of interest: The authors report no conflict of interest in this work.

Figures

Fig. 1
Fig. 1. Box and whisker plot (bupivacaine 0.25% on left, bupivacaine 0.5% on right). Abbreviation: VAS, visual analogue scale.
Fig. 2
Fig. 2. Mean VAS pain scores for bupivacaine 0.25% and bupivacaine 0.5% at 0.5, 2 and 24 h after surgery. Abbreviation: VAS, visual analogue scale.

Similar articles

Cited by

References

    1. Sancho-Puchades M, Vilchez-perez M, Valmaseda-Castellon E, Paredes-Garcia J, Berini-Aytes L, Gay-Escoda C. Bupivacaine 0.5% versus 4% for the removal of lower third molars. A crossover randomized controlled trial. Med Oral Patol Oral Cir Bucal. 2012;17:e462–e468. - PMC - PubMed
    1. Sisk AL. Long-acting local anaesthetics in dentistry. Anaesth Prog. 1992;39:53–60. - PMC - PubMed
    1. Valpato MC, Ranali J, Groppo FC. Anaesthetic efficacy of bupivacaine solutions in inferior alveolar nerve block. Anaesth Prog. 2005;52:132–135. - PMC - PubMed
    1. Moore PA. Bupivacaine: A long-standing local anaesthetic for dentistry. Oral Surg Oral Med Oral Pathol. 1984;58:369–374. - PubMed
    1. Bouloux GF, Punnia-Moorthy A. Bupivacaine versus lidocaine for third molar surgery: adouble-blind, randomized, crossover study. J Oral Maxillofac Surg. 1999;57:510–514. - PubMed